Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 77,000 shares, a growth of 26.9% from the February 13th total of 60,700 shares. Based on an average daily trading volume, of 268,300 shares, the days-to-cover ratio is presently 0.3 days.
Coloplast A/S Trading Up 0.7 %
Shares of OTCMKTS:CLPBY opened at $10.54 on Monday. The firm’s 50 day moving average price is $11.07 and its 200-day moving average price is $12.10. Coloplast A/S has a twelve month low of $10.43 and a twelve month high of $14.14. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. Research analysts predict that Coloplast A/S will post 0.31 EPS for the current year.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on CLPBY
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Read More
- Five stocks we like better than Coloplast A/S
- How to Calculate Return on Investment (ROI)
- How to Build the Ultimate Everything ETF Portfolio
- Growth Stocks: What They Are, What They Are Not
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.